Načítá se...
Use of fertility treatments in BRCA1/2 mutation carriers and risk for ovarian and breast cancer: a systematic review
PURPOSE: Mutations in the genes BRCA1 and BRCA2 represent a significant risk factor for ovarian and breast cancer. With increasing number and success rates, fertility protection and treatment are gaining importance also for BRCA1/2 mutation carriers. However, the effect on primary cancer risk and ri...
Uloženo v:
| Vydáno v: | Arch Gynecol Obstet |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7447664/ https://ncbi.nlm.nih.gov/pubmed/32719921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00404-020-05690-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|